Skip to main content

Advertisement

Table 4 Annualized total costs by inhibitor status (€; Euros)

From: Costs and utilization of treatment in patients with hemophilia

  Total cost P-value
With inhibitor (n = 5) 134,032 0.030
Without inhibitor (n = 98) 40,318  
  1. P value was computed using the Mann-Whitney U test